⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8630944 | 0.92 | — | — | |
| SCHEMBL29086599 | 0.77 | — | — | |
| SCHEMBL28551471 | 0.77 | — | — | |
| SCHEMBL29086606 | 0.77 | — | — | |
| SCHEMBL16609309 | 0.77 | — | — | |
| SCHEMBL16225018 | 0.77 | — | — | |
| SCHEMBL19500290 | 0.77 | — | — | |
| SCHEMBL1842503 | 0.77 | APLNR (0.31) | — | |
| SCHEMBL7415796 | 0.77 | — | — | |
| SCHEMBL7112910 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 96 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115465868-A | Thermal insulation material and high-permeability hydrophobic modification method thereof | 航天规划设计集团有限公司 | 2022-12-13 | — | — | CN | claimed |
| EP-4018013-A1 | MONOALKOXYSILANES AND DENSE ORGANOSILICA FILMS MADE THEREFROM | Versum Materials US, LLC (US) | 2022-06-29 | — | — | EP | claimed |
| CN-114616652-A | Monoalkoxysilanes and dense organosilica films prepared therefrom | 弗萨姆材料美国有限责任公司 | 2022-06-10 | — | — | CN | claimed |
| US-20040225135-A1 | Method of producing optically active lactone compound | KYUSHA UNIVERSITY (JP) | 2004-11-11 | — | — | US | claimed |
| EP-1449840-A1 | Method of producing optically active lactone compound | Kyushu University (JP) | 2004-08-25 | — | — | EP | claimed |
| WO-2000050478-A1 | NOVEL FORMULATIONS OF ALKYLLITHIUMS WITH IMPROVED THERMAL STABILITY, PROCESSES TO PRODUCE THESE FORMULATIONS AND PROCESSES FOR USING THE SAME TO IMPROVE STABILITY OF LIVING POLYMER CHAIN ENDS | FMC CORPORATION (US) | 2000-08-31 | — | — | WO | claimed |
| EP-1023333-A1 | PROCESSES FOR IMPROVING STABILITY OF LIVING POLYMERIZATION CHAIN ENDS | FMC CORPORATION (US) | 2000-08-02 | — | — | EP | claimed |
| WO-1999012979-A1 | PROCESSES FOR IMPROVING STABILITY OF LIVING POLYMERIZATION CHAIN ENDS | FMC CORPORATION (US) | 1999-03-18 | — | — | WO | claimed |
| EP-0525881-B1 | Catalyzed hydrocarbyllithium process | FMC CORP (US) | 1998-06-24 | — | — | EP | claimed |
| EP-0525880-B1 | Catalytic alkylation process | FMC CORP (US) | 1998-05-06 | — | — | EP | claimed |
| US-5663398-A | Processes for preparing functionalized alkyllithium compounds | FMC CORPORATION (US) | 1997-09-02 | — | — | US | claimed |
| US-5340507-A | Alkylating alkali metal with alkyl halide in hydrocarbon solvent in presence of specified catalyst | FMC CORPORATION (US) | 1994-08-23 | — | — | US | claimed |
| US-5332853-A | Alkylating tetrachlorosilane or an alkylchlorosilane with an alkyllithium using ether, metal alkoxide, amine, or metal amide as catalyst | FMC CORPORATION (US) | 1994-07-26 | — | — | US | claimed |
| US-5211888-A | Alkylation | FMC CORPORATION (US) | 1993-05-18 | — | — | US | claimed |
| EP-0525880-A1 | Catalytic alkylation process | FMC CORPORATION (US) | 1993-02-03 | — | — | EP | claimed |
| EP-0525881-A1 | Catalyzed hydrocarbyllithium process | FMC CORPORATION (US) | 1993-02-03 | — | — | EP | claimed |
| CN-119930589-A | Tricyclic compound, pharmaceutical composition and application | 广州国家实验室 | 2025-05-06 | — | — | CN | disclosed |
| US-11912674-B2 | Isoxazole derivatives as nuclear receptor agonists and uses thereof | IL DONG PHARMACEUTICAL CO., LTD. (KR) | 2024-02-27 | — | — | US | disclosed |
| EP-0525880-A1 | Catalytic alkylation process | FMC CORPORATION (US) | 1993-02-03 | — | — | EP | disclosed |
| US-4395418-A | 6-HYDROXYETHYL SUBSTITUTED ANTIBIOTICS | SANKYO COMPANY LIMITED (JP) | 1983-07-26 | — | — | US | disclosed |